Efficacy and safety of favipiravir plus interferon‐beta versus lopinavir/ritonavir plus interferon‐beta in moderately ill patients with COVID‐19: A randomized clinical trial

Journal of Medical Virology (2022) - Comments
doi: 10.1002/jmv.27724 issn: 0146-6615 issn: 1096-9071 pubmed: 35292989

Mehdi Hassaniazad, Hossein Farshidi, Abdollah Gharibzadeh, Ali Bazram, Elham Khalili, Afsaneh Noormandi, Mohammad Fathalipour